Research Initiative

 
Stock Quotes for Research Initiative top ^
  • Industry: Business Services
  • Sector: Industrials
  • Stock Style: Mid Value
Sign-up for rtoky investment picks
  • Industry: Communication Equipment
  • Sector: Technology
  • Stock Style: Mid Growth
Sign-up for iiji investment picks
  • Industry: Oil & Gas Equipment & Services
  • Sector: Energy
  • Stock Type: Distressed
Sign-up for usei investment picks
  • Industry: Solar
  • Sector: Technology
  • Stock Type: Distressed
Sign-up for sopv investment picks
  • Industry: Solar
  • Sector: Technology
  • Stock Type: Distressed
Sign-up for snry investment picks
  • Industry: Communication Equipment
  • Sector: Technology
  • Stock Style: Mid Growth
Sign-up for 3774 investment picks
  • Industry: Communication Equipment
  • Sector: Technology
  • Stock Style: Mid Growth
Sign-up for iiji investment picks
  • Industry: Internet Content & Information
  • Sector: Technology
  • Stock Style: Small Growth
Sign-up for 3658 investment picks
  • Industry: Solar
  • Sector: Technology
  • Stock Type: Distressed
Sign-up for snry investment picks

 
Fund Quotes for Research Initiative top ^
  • Category: Money Market-Taxable
Sign-up for fvusa00065 investment picks
  • Category: Money Market-Taxable
Sign-up for us55312g1013 investment picks

 
News Articles for Research Initiative top ^
2015/2/5
Intertain Agrees to Acquire Market Leading, Business-to-Consumer Assets from Gamesys Limited for an Initial Payment of Approximately £425.8 Million, Plus an Earn Out Canada NewsWire TORONTO , Feb.
Sign-up for Intertain Agrees to Acquire Market Leading, Business-to-Consumer Assets from Gamesys Limited for an Initial Payment of Approximately £425.8 Million, Plus an Earn Out investment picks
2015/1/9
http://www.ccnmatthews.com/logos2/223mmt.jpg CALGARY, ALBERTA --
Sign-up for Mart Resources, Inc.: UMU-13 Initial Flow Test Results, Drilling Update, and Dividend Update investment picks
2015/1/12
Conifer Health Solutions, the nation’s leading provider of technology-enabled healthcare performance improvement services, today announced a 10-year extension and expansion of its current agreement with Catholic Health Initiatives (CHI) to provide Patient Access, Revenue Integrity and Patient Financial Services to 76 CHI hospitals.
Sign-up for Conifer Health Solutions and Catholic Health Initiatives Expand Revenue Cycle Partnership investment picks
2015/2/17
Local Initiatives Support Corporation (LISC) Chicago recognized Chicago Neighborhood Initiatives (CNI) today with its Community Strategy of the Year Award at the annual Chicago Neighborhood Development Awards for CNI’s work to revitalize the Pullman neighborhood.
Sign-up for LISC Gives U.S. Bank-Founded Chicago Neighborhood Initiatives Its Community Strategy of the Year Award investment picks
2014/12/15
Hole KH-14-04 intersects 768 metres of 0.442 g/t Au and 0.392% Cu TORONTO , Dec.
Sign-up for AuRico Gold Announces a New Gold-Copper Porphyry Discovery at the Kemess Project; Initial Resource Estimate Expected in Early 2015 investment picks
2015/1/8
It will be a better new year for 3,500 people looking for work in 2015 as Accenture (NYSE:ACN) and Ashoka launch the Talent Growth Initiative (TGI), which not only provides skills training to unemployed and underemployed individuals, it helps place them in jobs.
Sign-up for Accenture and Ashoka Launch New Initiative to Place 3,500 Skilled Workers in Jobs investment picks
2015/2/4
Initial Investment to Help Research, Identify and Apply Innovative Solutions in Baltimore, Maryland and Jackson, Mississippi - Two of the Cities Hardest Hit by HIV/AIDS RESEARCH TRIANGLE PARK, N.C. , Feb.
Sign-up for ViiV Healthcare Announces $10 Million Initiative to Accelerate Response to HIV/AIDS Among Black Gay and Bisexual Men investment picks
2014/12/11
Alnylam Pharmaceuticals , Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today it has initiated the ENDEAVOUR Phase 3 clinical trial of revusiran in transthyretin (TTR)-mediated familial amyloidotic cardiomyopathy (FAC). FAC is one of the predominant clinical manifestations of TTR-mediated amyloidosis (ATTR), and afflicts an estimated 40,000 people worldwide.
Sign-up for Alnylam Initiates ENDEAVOUR Phase 3 Clinical Trial with Revusiran (ALN-TTRsc), an Investigational RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR Cardiac Amyloidosis investment picks
2014/12/29
Low dose oral Proellex ® study in women with fibroids and heavy menstrual bleeding initiated Vaginal administration of Proellex ® in women with fibroids and heavy menstrual bleeding initiated Company anticipates Type C meeting with FDA to discuss Phase 3 fibroid program and general NDA requirements around year end 2015 THE WOODLANDS, Texas, Dec.
Sign-up for Repros Initiates Two Phase 2B Uterine Fibroid Studies investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Initiative
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Infrastructure  |  Next: Research Institutes